← Back to Search

Behavioural Intervention

Arm A (Augmented Reality) for Cardiac Arrest

N/A
Waitlist Available
Led By Johan N Siebert, MD, PD
Research Sponsored by Johan Siebert, MD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants must have prior basic life support training
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 20 minutes
Awards & highlights

Study Summary

This trial will compare the use of augmented reality devices to the traditional AHA pocket reference card in pediatric emergency departments to see if it helps healthcare teams follow advanced life support guidelines better and reduce medication errors during

Who is the study for?
This trial is for healthcare teams in pediatric emergency departments. Participants must be able to perform cardiopulmonary resuscitation (CPR) and use either augmented reality tools or a pocket reference card during simulated cardiac arrest scenarios.Check my eligibility
What is being tested?
The study compares the effectiveness of an augmented reality tool versus a conventional AHA pocket reference card during CPR. It measures adherence to guidelines, performance, and medication errors in pediatric cardiac arrest situations.See study design
What are the potential side effects?
Since this trial involves simulation training with no direct patient interventions, there are no medical side effects expected from participating. However, participants may experience stress or fatigue due to the nature of emergency simulations.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have completed basic life support training.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~20 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 20 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Time to first dose of epinephrine
Secondary outcome measures
Cardiopulmonary resuscitation quality: Chest compression fraction
Cardiopulmonary resuscitation quality: Percentage of overall excellent cardiopulmonary resuscitation
Cardiopulmonary resuscitation quality: Peri-shock pause duration
+16 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Arm A (Augmented Reality)Experimental Treatment1 Intervention
Participants that will use the augmented reality supportive tool during the simulation-based pediatric scenario.
Group II: Arm B (Conventional methods)Active Control1 Intervention
Participants that will use conventional methods during the simulation-based pediatric scenario.

Find a Location

Who is running the clinical trial?

Johan Siebert, MDLead Sponsor
Geneva Children's Hospital, Geneva, SwitzerlandUNKNOWN
Alberta Children's Hospital, Calgary, CanadaUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new patients currently being actively recruited for this clinical trial?

"As per clinicaltrials.gov, at present, this research initiative is not accepting new participants. The trial's initial posting was on November 1st, 2024, with the last update made on April 18th of the same year. Despite its current inactivity, there are currently 108 alternative trials actively seeking potential candidates for participation."

Answered by AI

Does this study allow participants who have reached the age of 40?

"To be eligible for this research project, individuals aged between 18 and 70 are sought. There are a total of 41 trials catering to those under 18 and 72 studies dedicated to participants over the age of 65."

Answered by AI
~47 spots leftby Oct 2025